2013
DOI: 10.1074/jbc.m112.447276
|View full text |Cite
|
Sign up to set email alerts
|

The Nuclear Protein UHRF2 Is a Direct Target of the Transcription Factor E2F1 in the Induction of Apoptosis

Abstract: Background: E2F1-induced apoptosis kills oncogene-stressed cells, and regulators of this process may act as tumor suppressors. Results: We identified UHRF2 in a functional screen for mediators of E2F1 induced apoptosis. Conclusion: UHRF2 binds directly to E2F1 and is required for E2F1 induction of apoptosis and expression of several important apoptosis inducers. Significance: UHRF2 is a suspected tumor suppressor and our work suggests an anti-tumor mechanism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(26 citation statements)
references
References 47 publications
0
26
0
Order By: Relevance
“…Additionally, low expression of UHRF2 was found to be associated with vascular invasion, the malignant phenotype related to EMT, and poorer outcome regardless of tumor location or UICC stage. These inconsistent findings suggest that UHRF2 may be involved in organ-specific mechanisms through its multiple domains [16-20]. Thus, additional studies are needed to further elucidate the complex mechanisms of UHRF2 function.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, low expression of UHRF2 was found to be associated with vascular invasion, the malignant phenotype related to EMT, and poorer outcome regardless of tumor location or UICC stage. These inconsistent findings suggest that UHRF2 may be involved in organ-specific mechanisms through its multiple domains [16-20]. Thus, additional studies are needed to further elucidate the complex mechanisms of UHRF2 function.…”
Section: Discussionmentioning
confidence: 99%
“…The multiple domains of UHRF2 lead to complex functions; indeed, UHRF2 has been shown to be involved in the cell cycle network, epigenetic system, and ubiquitin proteasome system [13-15]. Hence, in several cancers, UHRF2 is dysregulated and acts as an oncogene [16, 17] or tumor-suppressor gene [18-20]. However, little is known about the biological and clinicopathological significance of UHRF2 in ESCC.…”
Section: Introductionmentioning
confidence: 99%
“…For another, E2F transcription factors can compete with NF-kappa B for binding at the Bnip3 (a positive regulator of autophagy) promoter, and attenuate the induction of Bnip3 by HIF-1 alpha [169]. Of note, AMPK alpha 2, an inducer of autophagy, is an E2F1 target gene required for its apoptotic activity, which would be interesting to elucidate the possible role AMPK alpha 2 has in E2F1-induced autophagy and to understand the relationship between E2F1-induced autophagy and E2F1-induced apoptosis [170][171][172]. 7.…”
Section: Other Important Transcription Factors Of Autophagy Regulatiomentioning
confidence: 99%
“…The role of E2F transcription factors in controlling the gene expression central to the cell cycle and cell fate decisions has been well documented, and there is evidence of a complex combinatorial mechanism of gene regulation involving E2F proteins together with other cooperating transcriptional regulators . This includes regulatory cascades in which E2Fs activate the expression of genes encoding other transcription factors and then cooperate with these induced factors to regulate additional target genes, a relationship known as a feed‐forward regulatory loop . This has been reported for E2F1 and NFYB as well as for DREAM and FOXM1, the latter belonging to the CINSARC gene set.…”
Section: Introductionmentioning
confidence: 97%